Author

L. Berhelin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Djiane· 1 shared C. Gongora· 1 shared D. Kantar· 1 shared D. Tosi· 1 shared L. Heron-Milhavet· 1 shared L. Jeanson· 1 shared M. Robin· 1 shared V. Slaninova· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Djiane

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in colon cancer cells

V. Slaninova, L. Heron-Milhavet, M. Robin, L. Jeanson, D. Kantar, D. Tosi, L. Berhelin, C. Gongora, A. Djiane

The paper shows that TAZ/WWTR1 promotes oxaliplatin sensitivity in colon cancer cells through nuclear accumulation, independent of P73 but requiring DNA damage and P53 activity.

bioRxiv · Mar 17, 2023 · PreprintCancer Biology